Fidelity International’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,491,000
Closed -$151M 1134
2025
Q4
$151M Buy
1,491,000
+1,487,882
+47,719% +$119M 0.11% 195
2025
Q3
$171K Buy
+3,118
New +$156K ﹤0.01% 893
2024
Q4
Sell
-5,049
Closed -$344K 939
2024
Q3
$344K Buy
+5,049
New +$285K ﹤0.01% 809
2017
Q3
Sell
-41,391
Closed -$1.46M 507
2017
Q2
$1.46M Sell
41,391
-582,399
-93% -$18M ﹤0.01% 464
2017
Q1
$14.7M Sell
623,790
-36,896
-6% -$731K 0.04% 298
2016
Q4
$8.83M Buy
660,686
+527,826
+397% +$8.52M 0.03% 344
2016
Q3
$2.47M Sell
132,860
-807,477
-86% -$14.2M 0.01% 450
2016
Q2
$11.5M Buy
+940,337
New +$7.08M 0.04% 320
2015
Q4
Sell
-795,855
Closed -$14.3M 499
2015
Q3
$14.3M Sell
795,855
-54,900
-6% -$1.26M 0.05% 291
2015
Q2
$25.3M Buy
850,755
+305,421
+56% +$7.67M 0.08% 232
2015
Q1
$12M Buy
545,334
+308,176
+130% +$7.82M 0.04% 341
2014
Q4
$6.51M Sell
237,158
-87,643
-27% -$2.13M 0.02% 384
2014
Q3
$6.29M Sell
324,801
-110,802
-25% -$2.03M 0.02% 380
2014
Q2
$7.42M Sell
435,603
-293,764
-40% -$4.04M 0.03% 368
2014
Q1
$10.3M Buy
+729,367
New +$9.85M 0.04% 336

Other funds holding EXAS

Fidelity International's EXAS Position: Q1 2026 in Review

Fidelity International sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 1,491,000 shares — an estimated $151M sold.

Fidelity International first reported a position in EXAS in Q1 2014 and held it in 15 quarters. The position peaked at $151M in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Fidelity International reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Fidelity International sold 1,491,000 Exact Sciences shares in Q1 2026, an estimated $151M.
  • Fidelity International first reported a position in Exact Sciences in Q1 2014 and held it in 15 quarters.
  • Fidelity International's Exact Sciences position peaked at $151M in Q4 2025.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Fidelity International's 13F filing for Q1 2026, filed 15 May 2026.